Belize - Press Releases

LOS ANGELES, Feb. 14, 2025 /PRNewswire/ -- KessCo announced today an exciting collaboration with Bandai to bring Tamagotchi fans a brand-new tabletop experience, the Tamagotchi Collections. This cozy board game reimagines the nostalgic virtual pets as charming visitors who crash-land on Earth, ready to be fed, played with, and lovingly cared for. Designed for two to four players, the game invites families, collectors, and pop culture enthusiasts to compete for the highest score by hosting as many happy Tamagotchi characters as possible.

The York Pain Center es pionero en un nuevo modelo de atencin para manejar el dolor crnico y para ello, combina tecnologa innovadora de sensores con ciencia de datos y aprendizaje automtico para promover la adherencia, identificar riesgos para la salud e impulsar resultados clnicos.

National and regional leaders will gather to discuss strategies to strengthen support networks across the I-85 Corridor

Bipartisan legislation would waive prostate cancer screening cost-sharing for high-risk populationsand save lives

Grand Opening Set for Feb. 15 at Eastpoint Mall

This iconic House of the Lord will reopen for public tours from April to October 2027

RACINE,Wis., Feb. 14, 2025 /PRNewswire/ --Babyganics has issued a voluntary recall of specific lots of its Totally Tropical scented mineral sunscreen rollerball and continuous spray formulas. Consumers who have purchased Totally Tropical rollerball or continuous spray sunscreen can visit www.babyganicssunscreenrecall.com to determine if their product is impacted by this recall and receive a refund for their purchase.

Formation of The Miller Institute for DemocracyAdvances BBYO's Commitment to Leadership Development

The tip came in through Sandy Hook Promise's Say Something Anonymous Reporting System. FBI investigation confirmed the threat was credible.

"Ama tu corazn. Baja la presin." presenta historias de personas reales que viven con presin arterial alta

"Love your heart. Lower the Pressure." features stories of real people living with high blood pressure

Non-Profit to Pay Tribute to Community Activists and Partners While Fundraising for LA Fire Relief and Supporting Mental Health Through Creative Arts Programming

VALLEY, Ala., Feb. 14, 2025 /PRNewswire/ --

Offers a Robust Line-Up of Family-Friendly Activities

BALTIMORE, Feb. 15, 2025 /PRNewswire/ -- The National Federation of the Blind strongly condemns the inappropriate and harmful stereotyping of blind people that has been highlighted in the response to a recent Congressional hearing before the House Committee on Oversight and Government Reform Subcommittee on Delivering on Government Efficiency. The online mockery and skepticism directed at a blind witness reflect a broader aggressive and deeply troubling pattern in today's political discourse-one that wrongly assumes blind people, and people with disabilities more generally, lack the capacity to participate fully in public life, including in complex and technical fields. We specifically condemn all media outlets that are actively perpetuating these horrible misconceptions and are falsely validating low expectations that harm our society.

NASDAQ | TSX: ACB

YANTAI, China, Feb. 15, 2025 /PRNewswire/ -- On the morning of February 14, 2025 (UTC-8), at the ongoing 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) held in San Francisco, USA, Professor Xinan Sheng from Peking University Cancer Hospital delivered the latest efficacy and safety data from the phase II clinical trial (NCT05297552, Study ID: RC48-C017) of Disitamab Vedotin (DV) in combination Toripalimab as the neoadjuvant therapy for HER2-expressing muscle-invasive bladder cancer (MIBC) in an oral presentation. This marks the first public disclosure of results from a prospective clinical study investigating an ADC drug in combination with an immunotherapy as a perioperative therapy for MIBC. The pathological complete response (pCR) rate reached an impressive 63.6%, which is a breakthrough improvement compared with traditional neoadjuvant chemotherapies (36%-42%). ASCO GU is one of the top urologic oncology conferences that leading experts worldwide in this field attend.

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The globalgender reassignment surgery market size is estimated to grow by USD 374.2 million from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over11.2% during the forecast period. Increase in number of people opting for sex change surgeries globallyis driving market growth,with a trend towardsadvancements in medical technology. However,high cost of surgeries poses a challenge. Key market players include Andrew Ives., Boston Childrens Hospital, Boston Medical Center, Chettawut Plastic Surgery Center, CNY Cosmetic and Reconstructive Surgery, Crane Center, Icahn School of Medicine at Mount Sinai, IVAN MANERO CLINIC S.L., Moein Surgical Arts, Oregon Health and Science University, Phuket International Aesthetic Centre PIAC, Plastic Surgery Group of Rochester, Regents of the University of Michigan, Rumer Cosmetic Surgery, Sava Perovic Foundation Surgery, The Johns Hopkins Health System Corp., Transgender Surgery Institute, and University of Pennsylvania Health System.

VIRGINIA BEACH, Va., Feb. 15, 2025 /PRNewswire/ -- LifeNet Health proudly announces the launch of OraGen, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone containing endogenous lineage-committedbone cells combined with demineralized bone matrix. This unique composition, the core of OraGen's innovation, delivers three essential properties for bone regeneration: osteogenicity, with lineage-committed bone cells that produce new bone; osteoconductivity, providing a biocompatible scaffold for cell attachment and growth; and osteoinduction, which stimulates bone repair through retained natural growth factors.

Bahnbrechende Technologie kombiniert rekombinantes menschliches Kollagen und Hyaluronsure fr sofortige, lang anhaltende Ergebnisse

SUN PRAIRIE, Wis., Feb. 16, 2025 /PRNewswire/ -- Independent Pharmacy Cooperative (IPC),the leading Group Purchasing Organization (GPO) for independent pharmacies nationwide, is thrilled to announce a groundbreaking cooperation agreement with Legacy Pharmacy Group (LPG). This strategic partnership aims to enhance the capabilities and offerings for both organizations, benefiting our members and advancing independent pharmacy.

Revolutionising Vascular Access Care for Critically Ill Newborns and Children

SAN FRANCISCO and SUZHOU, China, Feb. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that its first-in-class PD-1/IL-2-bias bispecific antibody fusion protein, IBI363, has received its second Fast Track Designation (FTD) from the U.S. Food and Drug Administration (FDA). This designation applies to the treatment of unresectable, locally advanced, or metastatic squamous non-small cell lung cancer (sqNSCLC) that has progressed following anti-PD-(L)1 immune checkpoint inhibitor therapy and platinum-based chemotherapy. IBI363 has demonstrated encouraging efficacy and safety across multiple solid tumor types. Currently, Innovent is conducting Phase 1/2 clinical trials of IBI363 mainly in China and the U.S.

TAIPEI, Feb. 17, 2025 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces thethird positive safety review by the independentData and Safety Monitoring Board for its Casppian Phase 3 registration study. The DSMB recommended that Foresee Pharmaceuticalscontinue the trial as planned without any modification.

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The e-cigarette market in UK and it is set to grow by USD 1.47 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of 13.6% during the forecast period, according to Technavio. The e-cigarette market in UK is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market. 1111EC Service Ltd., British American Tobacco Plc, Flavour Warehouse Ltd., Geekvape, Imperial Brands Plc, Innokin Technology Ltd., J WELL France Sarl, Japan Tobacco Inc., LOSTVAPE, Pax Labs Inc., Philip Morris International Inc., RELX International Enterprise HK Ltd., Shenzhen IVPS Technology Co Ltd., SMOORE International Holdings Ltd., and VOOPOO are some of the major market participants -.